| Literature DB >> 24957994 |
Abstract
The "Critical Assessment of Small Molecule Identification" (CASMI) contest was aimed in testing strategies for small molecule identification that are currently available in the experimental and computational mass spectrometry community. We have applied tandem mass spectral library search to solve Category 2 of the CASMI Challenge 2012 (best identification for high resolution LC/MS data). More than 230,000 tandem mass spectra part of four well established libraries (MassBank, the collection of tandem mass spectra of the "NIST/NIH/EPA Mass Spectral Library 2012", METLIN, and the 'Wiley Registry of Tandem Mass Spectral Data, MSforID') were searched. The sample spectra acquired in positive ion mode were processed. Seven out of 12 challenges did not produce putative positive matches, simply because reference spectra were not available for the compounds searched. This suggests that to some extent the limited coverage of chemical space with high-quality reference spectra is still a problem encountered in tandem mass spectral library search. Solutions were submitted for five challenges. Three compounds were correctly identified (kanamycin A, benzyldiphenylphosphine oxide, and 1-isopropyl-5-methyl-1H-indole-2,3-dione). In the absence of any reference spectrum, a false positive identification was obtained for 1-aminoanthraquinone by matching the corresponding sample spectrum to the structurally related compounds N-phenylphthalimide and 2-aminoanthraquinone. Another false positive result was submitted for 1H-benz[g]indole; for the 1H-benz[g]indole-specific sample spectra provided, carbazole was listed as the best matching compound. In this case, the quality of the available 1H-benz[g]indole-specific reference spectra was found to hamper unequivocal identification.Entities:
Year: 2013 PMID: 24957994 PMCID: PMC3901269 DOI: 10.3390/metabo3020312
Source DB: PubMed Journal: Metabolites ISSN: 2218-1989
Putative identifications submitted.
| Challenge | Matched compound(s) | Library | Score | Correct compound |
|---|---|---|---|---|
| 1 | Kanamycin A | MassBank, NIST MS/MS 2012, Wiley Registry MS/MS | 1.0 | Kanamycin A |
| 10 | N-Phenylphthalimide | Wiley Registry | 1.0 | 1-Aminoanthraquinone |
| 2-Aminoanthraquinone | MS/MS | 0.84 | ||
| 13 | Benzyldiphenylphosphine oxide | MassBank | 1.0 | Benzyldiphenylphosphine oxide |
| 14 | Carbazole | MassBank | 1.0 | 1H-Benz[g]indole |
| 1H-benz[g]indole | 0.99 | |||
| 15 | 1-Isopropyl-5-methyl-1H-indole-2,3-dione | MassBank | 1.0 | 1-Isopropyl-5-methyl-1H-indole-2,3-dione |
Putative identifications with MassBank. Unless otherwise stated, information on the best matching compound only is provided.
| Challenge | CE | Matched compound(s) | Accession | Score |
|---|---|---|---|---|
| 1 | 10 eV | Kanamycin A (2nd place in hit list) | KO009014 | 0.733 |
| 20 eV | Kanamycin A | KO009015 | 0.874 | |
| 30 eV | Kanamycin A (2nd place in hit list) | KO009015 | 0.773 | |
| 13 | 25% | Benzyldiphenylphosphine oxide | UF011001 | 0.986 |
| 45% | Benzyldiphenylphosphine oxide | UF011003 | 0.995 | |
| HCD 45 | Benzyldiphenylphosphine oxide | UF011007 | 0.996 | |
| HCD 75 | Benzyldiphenylphosphine oxide | UF011009 | 0.967 | |
| 14 | HCD 120 | Carbazole (2nd place in hit list) | UF026312 | 0.807 |
| 1H-Benz[g]indole (7th place in hit list) | UF011409 | 0.725 | ||
| HCD 180 | Carbazole | UF026314 | 0.819 | |
| 1H-Benz[g]indole (3rd place in hit list) | UF011413 | 0.801 | ||
| 15 | HCD 120 | 1-Isopropyl-5-methyl-1H-indole-2,3-dione | UF011512 | 0.968 |
| HCD 90 | 1-Isopropyl-5-methyl-1H-indole-2,3-dione | UF011510 | 0.971 |
Figure 1Comparison of (a) the HCD 180 sample spectrum of Challenge 14 with (b) the spectrum of the best matching compound and (c) the spectrum of the correct compound. The two reference spectra (b,c) were extracted from MassBank.
Putative identifications with the NIST MS/MS 2012 database. Information on the best matching compound only is provided.
| Challenge | CE | Matched compound | MF | RMF | Prob |
|---|---|---|---|---|---|
| 1 | 10 eV | Kanamycin A | 645 | 879 | 98.88 |
| 20 eV | Kanamycin A | 501 | 833 | 98.81 | |
| 30 eV | Kanamycin A | 531 | 776 | 98.66 |
Putative identifications with the Wiley Registry MS/MS. Unless otherwise stated, information on the best matching compound only is provided.
| Challenge | CE | Matched compound(s) |
|
| Delta |
|---|---|---|---|---|---|
| 1 | 10 eV | Tobramycin | 72.03 | 468.2665 | 16.9788 |
| 20 eV | Tobramycin | 68.43 | 468.2665 | 16.9788 | |
| 30 eV | Tobramycin | 65.85 | 468.2665 | 16.9788 | |
| 10 | 35% | N-Phenylphthalimide (1st place in hit list) | 54.1 | 224.0707 | 0.0004 |
| 2-Aminoanthraquinone (2nd place in hit list) | 45.6 | 224.0707 | 0.0004 |
Putative identifications with the extended Wiley Registry MS/MS. Unless otherwise stated, information on the best matching compound only is provided.
| Challenge | CE | Matched compound(s) |
|
| Delta |
|---|---|---|---|---|---|
| 1 | 10 eV | Kanamycin A | 98.84 | 485.2454 | -0.0001 |
| 20 eV | Kanamycin A | 98.46 | 485.2454 | -0.0001 | |
| 30 eV | Kanamycin A | 98.46 | 485.2454 | -0.0001 | |
| 10 | 35% | N-Phenylphthalimide (1st place in hit list) | 36.05 | 224.0707 | 0.0004 |
| 1-Aminoanthraquinone (2nd place in hit list) | 33.37 | 224.0707 | 0.0004 | ||
| 2-Aminoanthraquinone (3rd place in hit list) | 30.39 | 224.0707 | 0.0004 | ||
| 13 | 25% | Benzyldiphenylphosphine oxide | 81.58 | 293.1090 | 0.0007 |
| 45% | Benzyldiphenylphosphine oxide | 91.53 | 293.1090 | 0.0007 | |
| HCD 45 | Benzyldiphenylphosphine oxide | 84.05 | 293.1090 | 0.0007 | |
| HCD 75 | Benzyldiphenylphosphine oxide | 83.25 | 293.1090 | 0.0007 | |
| 14 | HCD 120 | 1H-Benz[g]indole (1st place in hit list) | 80.30 | 168.0808 | -0.0004 |
| Carbazole (2nd place in hit list) | 18.86 | 168.0808 | -0.0004 | ||
| HCD 180 | 1H-Benz[g]indole (1st place in hit list) | 67.04 | 168.0808 | -0.0004 | |
| Carbazole (2nd place in hit list) | 30.91 | 168.0808 | -0.0004 |
Figure 2Comparison of the sample spectrum provided for Challenge 10 with the merged spectra of (a) 1-aminoanthraquinone, (b) 2-aminoanthraquinone, and (c) N-phenylphthalimide. Each line in the merged spectra represents a fragment ion; the corresponding signal intensities are not provided.